
Medical sleuths identify potential of baricitinib for COVID-19 by using artificial intelligence to sift through available agents that act on receptors of interest.

Medical sleuths identify potential of baricitinib for COVID-19 by using artificial intelligence to sift through available agents that act on receptors of interest.

HIV training pathways in residency have added 90 HIV physicians to the workforce since 2006.

Thomas Dilworth, PharmD, provides a recap of ACEIs, ARBs, and NSAIDs in patients with COVID-19.

The system can be used among adult patients with COVID-19 who have been admitted to the ICU and are currently experiencing or will experience respiratory failure.

Check out the latest coronavirus updates from Thursday, April 9th.

When drug resistance means ART options are exhausted, HIV patients need newer choices. A new study shows that novel prodrug fostemsavir is an effective alternative.

Jason Kindrachuk, PhD, explains the animal reservoir spillover events involved in the emergence of viruses like SARS-CoV-2.

As governments and tech companies rush to find ways to use technology to track the spread of the novel coronavirus, a new paper cautions governments against going so quickly that they ignore privacy concerns.

The study authors followed up with 19 patients with pancreatic echinococcosis after their surgeries, as well as collected their treatment journeys.

The trial will evaluate the safety and effectiveness of the agent in adults who are hospitalized with the novel virus

Krutika N. Mediwala, PharmD, BCPS, BCIDP, provides a recap of available information regarding Kaletra for the treatment of COVID-19.

Stay up to date on the latest COVID-19 news for April 8, 2020.

Robert Salata, MD, discusses the ARMS-I clinical trial that will enroll clinical staff caring for patients with COVID-19.

Jason Kindrachuk, PhD, addresses clinician questions about SARS-CoV-2 such as the length of infectious viral shedding and whether the virus will become endemic.

While school closures reduce case transmission of COVID-19, they may also reduce the capacity of a strained health care labor force.

Anthony Fauci, MD, of NIAID, Robert Redfield, MD, of CDC, and others considered initial epidemiology from Wuhan China, and the need to obtain, and act on new data.

AEI’s report outlines needed steps for country to return to health—and business.

Wendy M. Bamberg, MD, the editor of Contagion®’s Emerging and Re-emerging Infections section, shares her thoughts on social distancing, managing suspect cases, and lessons we can learn about COVID-19.

The FDA has granted an Emergency Use Authorization to the Cellex qSARS-CoV-2 IgG/IgM Rapid Test

Data on the epidemiology and clinical characteristics of pediatric cases of COVID-19 in the United States are now emerging.

Stay up to date on the latest coronavirus updates from Tuesday April 7th.

A new analysis in the CDC’s MMWR points to success in ART initiation and viral suppression among active duty members of the US armed forces.

Investigators from the University of Oxford say a mobile app could quickly identify contacts of persons infected with COVID-19 and alert those people of the need to self-isolate.

The city of Wuhan, China has eased controls on travel outside of the city after a lengthy lockdown.

A look at what key questions still have to be answered about COVID-19.

Jason Kindrachuk, PhD, situates the virus which causes COVID-19 in the context of past coronavirus outbreaks. This is part 1 of a 3-part interview.

Now more than ever, modeling is being used to address the global pandemic that is COVID-19.

Diabetics and patients taking glucocorticoids may be at increased risk for COVID-19 and more severe disease.

The CDC will produce a weekly report called COVIDView. The report will be updated each Friday with US-based surveillance information.

Catch up on the latest coronavirus news from April 6, 2020.